155 related articles for article (PubMed ID: 28698067)
1. Glycyrrhetinic acid-modified TPGS polymeric micelles for hepatocellular carcinoma-targeted therapy.
Zhu X; Tsend-Ayush A; Yuan Z; Wen J; Cai J; Luo S; Yao J; Bian J; Yin L; Zhou J; Yao J
Int J Pharm; 2017 Aug; 529(1-2):451-464. PubMed ID: 28698067
[TBL] [Abstract][Full Text] [Related]
2. Glycyrrhetinic Acid-Mediated Polymeric Drug Delivery Targeting the Acidic Microenvironment of Hepatocellular Carcinoma.
Zhang J; Zhang M; Ji J; Fang X; Pan X; Wang Y; Wu C; Chen M
Pharm Res; 2015 Oct; 32(10):3376-90. PubMed ID: 26148773
[TBL] [Abstract][Full Text] [Related]
3. Micelles of d-α-Tocopheryl Polyethylene Glycol 2000 Succinate (TPGS 2K) for Doxorubicin Delivery with Reversal of Multidrug Resistance.
Hao T; Chen D; Liu K; Qi Y; Tian Y; Sun P; Liu Y; Li Z
ACS Appl Mater Interfaces; 2015 Aug; 7(32):18064-75. PubMed ID: 26214761
[TBL] [Abstract][Full Text] [Related]
4. Lactobionic acid-conjugated TPGS nanoparticles for enhancing therapeutic efficacy of etoposide against hepatocellular carcinoma.
Tsend-Ayush A; Zhu X; Ding Y; Yao J; Yin L; Zhou J; Yao J
Nanotechnology; 2017 May; 28(19):195602. PubMed ID: 28291743
[TBL] [Abstract][Full Text] [Related]
5. Development and evaluation of a novel drug delivery: Soluplus
Ding Y; Wang C; Wang Y; Xu Y; Zhao J; Gao M; Ding Y; Peng J; Li L
Drug Dev Ind Pharm; 2018 Sep; 44(9):1409-1416. PubMed ID: 29718714
[TBL] [Abstract][Full Text] [Related]
6. Glycyrrhetinic acid-decorated and reduction-sensitive micelles to enhance the bioavailability and anti-hepatocellular carcinoma efficacy of tanshinone IIA.
Chen F; Zhang J; He Y; Fang X; Wang Y; Chen M
Biomater Sci; 2016 Jan; 4(1):167-82. PubMed ID: 26484363
[TBL] [Abstract][Full Text] [Related]
7. TPGS-g-PLGA/Pluronic F68 mixed micelles for tanshinone IIA delivery in cancer therapy.
Zhang J; Li Y; Fang X; Zhou D; Wang Y; Chen M
Int J Pharm; 2014 Dec; 476(1-2):185-98. PubMed ID: 25223472
[TBL] [Abstract][Full Text] [Related]
8. Folic acid modified TPGS as a novel nano-micelle for delivery of nitidine chloride to improve apoptosis induction in Huh7 human hepatocellular carcinoma.
Li D; Liu S; Zhu J; Shen L; Zhang QY; Zhu H
BMC Pharmacol Toxicol; 2021 Jan; 22(1):1. PubMed ID: 33407916
[TBL] [Abstract][Full Text] [Related]
9. Galactosylated TPGS Micelles for Docetaxel Targeting to Hepatic Carcinoma: Development, Characterization, and Biodistribution Study.
Tekchandani P; Kurmi BD; Paliwal R; Paliwal SR
AAPS PharmSciTech; 2020 Jun; 21(5):174. PubMed ID: 32548786
[TBL] [Abstract][Full Text] [Related]
10. Combinatorial delivery of Crizotinib-Palbociclib-Sildenafil using TPGS-PLA micelles for improved cancer treatment.
de Melo-Diogo D; Gaspar VM; Costa EC; Moreira AF; Oppolzer D; Gallardo E; Correia IJ
Eur J Pharm Biopharm; 2014 Nov; 88(3):718-29. PubMed ID: 25308930
[TBL] [Abstract][Full Text] [Related]
11. Formulation of pluronic F127/TPGS mixed micelles to improve the oral absorption of glycyrrhizic acid.
Shen C; Zhu J; Song J; Wang J; Shen B; Yuan H; Li X
Drug Dev Ind Pharm; 2020 Jul; 46(7):1100-1107. PubMed ID: 32463722
[No Abstract] [Full Text] [Related]
12. Preparation, in vitro and in vivo evaluation of polymeric nanoparticles based on hyaluronic acid-poly(butyl cyanoacrylate) and D-alpha-tocopheryl polyethylene glycol 1000 succinate for tumor-targeted delivery of morin hydrate.
Abbad S; Wang C; Waddad AY; Lv H; Zhou J
Int J Nanomedicine; 2015; 10():305-20. PubMed ID: 25609946
[TBL] [Abstract][Full Text] [Related]
13. Hepatocellular carcinoma dually-targeted nanoparticles for reduction triggered intracellular delivery of doxorubicin.
Mezghrani O; Tang Y; Ke X; Chen Y; Hu D; Tu J; Zhao L; Bourkaib N
Int J Pharm; 2015 Jan; 478(2):553-68. PubMed ID: 25455765
[TBL] [Abstract][Full Text] [Related]
14. TPGS functionalized mesoporous silica nanoparticles for anticancer drug delivery to overcome multidrug resistance.
Zhao P; Li L; Zhou S; Qiu L; Qian Z; Liu X; Cao X; Zhang H
Mater Sci Eng C Mater Biol Appl; 2018 Mar; 84():108-117. PubMed ID: 29519418
[TBL] [Abstract][Full Text] [Related]
15. Ascorbyl palmitate/d-α-tocopheryl polyethylene glycol 1000 succinate monoester mixed micelles for prolonged circulation and targeted delivery of compound K for antilung cancer therapy in vitro and in vivo.
Zhang Y; Tong D; Che D; Pei B; Xia X; Yuan G; Jin X
Int J Nanomedicine; 2017; 12():605-614. PubMed ID: 28144142
[TBL] [Abstract][Full Text] [Related]
16. Alpha-tocopheryl polyethylene glycol succinate-emulsified poly(lactic-co-glycolic acid) nanoparticles for reversal of multidrug resistance in vitro.
Wang Y; Guo M; Lu Y; Ding LY; Ron WT; Liu YQ; Song FF; Yu SQ
Nanotechnology; 2012 Dec; 23(49):495103. PubMed ID: 23149859
[TBL] [Abstract][Full Text] [Related]
17. Glycyrrhetinic acid-functionalized degradable micelles as liver-targeted drug carrier.
Huang W; Wang W; Wang P; Zhang CN; Tian Q; Zhang Y; Wang XH; Cha RT; Wang CH; Yuan Z
J Mater Sci Mater Med; 2011 Apr; 22(4):853-63. PubMed ID: 21373811
[TBL] [Abstract][Full Text] [Related]
18. Enhanced anticancer activity in vitro and in vivo of luteolin incorporated into long-circulating micelles based on DSPE-PEG2000 and TPGS.
Yan H; Wei P; Song J; Jia X; Zhang Z
J Pharm Pharmacol; 2016 Oct; 68(10):1290-8. PubMed ID: 27465923
[TBL] [Abstract][Full Text] [Related]
19. Formulation of Docetaxel by folic acid-conjugated d-α-tocopheryl polyethylene glycol succinate 2000 (Vitamin E TPGS(2k)) micelles for targeted and synergistic chemotherapy.
Mi Y; Liu Y; Feng SS
Biomaterials; 2011 Jun; 32(16):4058-66. PubMed ID: 21396707
[TBL] [Abstract][Full Text] [Related]
20. Cleavable Multifunctional Targeting Mixed Micelles with Sequential pH-Triggered TAT Peptide Activation for Improved Antihepatocellular Carcinoma Efficacy.
Zhang J; Zheng Y; Xie X; Wang L; Su Z; Wang Y; Leong KW; Chen M
Mol Pharm; 2017 Nov; 14(11):3644-3659. PubMed ID: 28994600
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
